Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season
Authors
Keywords
Influenza, Vaccines, Influenza A virus, Influenza viruses, Viral vaccines, Vaccination and immunization, Influenza B virus, Polymerase chain reaction
Journal
PLoS One
Volume 15, Issue 2, Pages e0229279
Publisher
Public Library of Science (PLoS)
Online
2020-02-27
DOI
10.1371/journal.pone.0229279
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparing influenza vaccine effectiveness between cell-derived and egg-derived vaccines, 2017–2018 influenza season
- (2019) Laurie DeMarcus et al. VACCINE
- Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017–2018
- (2019) Katia J. Bruxvoort et al. VACCINE
- Update: Influenza Activity in the United States During the 2017–18 Season and Composition of the 2018–19 Influenza Vaccine
- (2018) Rebecca Garten et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Influenza Vaccine Effectiveness in the United States during the 2016–2017 Season
- (2018) Brendan Flannery et al. CLINICAL INFECTIOUS DISEASES
- End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17
- (2017) Richard Pebody et al. Eurosurveillance
- Influenza Vaccine Effectiveness in the United States during the 2015–2016 Season
- (2017) Michael L. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
- (2017) Seth J. Zost et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine
- (2017) Nicholas C. Wu et al. PLoS Pathogens
- Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness
- (2016) Sheena G. Sullivan et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- 2014–2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type
- (2016) Richard K. Zimmerman et al. CLINICAL INFECTIOUS DISEASES
- Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies
- (2016) Edward A Belongia et al. LANCET INFECTIOUS DISEASES
- Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada’s Sentinel Physician Surveillance Network, January 2015
- (2015) D M Skowronski et al. Eurosurveillance
- Influenza Vaccine Effectiveness in the United States During 2012-2013: Variable Protection by Age and Virus Type
- (2014) H. Q. McLean et al. JOURNAL OF INFECTIOUS DISEASES
- Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses
- (2014) Danuta M. Skowronski et al. PLoS One
- Influenza Vaccine Effectiveness in the Community and the Household
- (2013) S. E. Ohmit et al. CLINICAL INFECTIOUS DISEASES
- The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials
- (2013) G De Serres et al. Eurosurveillance
- The test-negative design for estimating influenza vaccine effectiveness
- (2013) Michael L. Jackson et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started